TransMedics (TMDX) EBITDA Margin Growth (5y) (2023 - 2026)
TransMedics (TMDX) EBITDA Margin Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn |
| 10 | TransMedics | 3.22 Bn | 2.75 Bn | 113.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12,635.00 |
| Mar 31, 2026 | 9,285.00 |
| Dec 31, 2025 | 9,054.00 |
| Sep 30, 2025 | 7,402.00 |
| Jun 30, 2025 | 22,362.00 |
| Mar 31, 2025 | 12,559.00 |
| Dec 31, 2024 | 15,064.00 |
| Sep 30, 2024 | 10,412.00 |
| Jun 30, 2024 | 14,693.00 |
| Mar 31, 2024 | 14,033.00 |
| Dec 31, 2023 | 18,269.00 |
| Sep 30, 2023 | 5,487.00 |
| Jun 30, 2023 | 17,515.00 |
| Mar 31, 2023 | 18,477.00 |